PanGenex Corporation Expands Clinical Trial Sites after Promising Pre-Clinical Data about Lower Coronary Arterial Calcium Scores in Cardiac Patients

TAMPA, Fla.--(BUSINESS WIRE)--PanGenex Corporation (Pink Sheets: PGCX) (“PanGenex” or “the Company”) announced that due to promising pre-clinical results from its clinical trial at the Cardiovascular Institute of the South (http://www.cardio.com/site1.php), the Company will extend its trial to two additional sites.